Clinical Trial Detail

NCT ID NCT02830594
Title Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

gastroesophageal junction adenocarcinoma

stomach carcinoma

esophageal carcinoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.